Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery
<b>Background:</b> Ketamine HCl, an FDA-approved therapeutic, is administered through various routes, including intranasal delivery. Administering an adequate therapeutic dose of intranasal ketamine HCl is challenging due to the limited volume that can be delivered intranasally given the...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/12/1502 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|